B.FAB
B.fab specializes in the conversion of CO2 and hydrogen from renewable energy into biotechnological value chains. It utilizes formate as its central mediator to bind and store CO2 and H2 (made from water) in liquid form. The company's bioprocesses start with the feedstock formate and it uses synthetic biology to design specific pathways and to convert formate into value-added chemicals. The platform is built on anaerobic and aerobic microbial production hosts to provide flexibility in the proce... ss design and adaptation to specific product requirements. B.fab GmbH applies laboratory automation, high-throughput experimentation, and advanced bioprocess development in an agile environment to develop new bioprocesses efficiently and in a minimal time frame. It was founded in 2018 in Dortmund, Nordrhein-Westfalen.
B.FAB
Social Links:
Industry:
Biotechnology Life Science Sustainability
Founded:
2018-01-01
Address:
Köln, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.bfab.bio
Total Employee:
1+
Status:
Active
Contact:
+49-231-55033770
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API WordPress Content Delivery Network Font Awesome JsDelivr Contact Form 7
Similar Organizations
Merck Accelerator
Merck Accelerator program supports startups in the fields of healthcare, life science, performance materials and additional search fields.
Novalis Biotechnology Incubation
Novalis Biotech Incubation is an early-stage vc fund that invests in biotechnology and life sciences related companies.
Current Employees Featured
Founder
Investors List
b.value AG
b.value AG investment in Seed Round - b.fab
German Federal Ministry of Education and Research
German Federal Ministry of Education and Research investment in Grant - b.fab
Official Site Inspections
http://www.bfab.bio Semrush global rank: 14.86 M Semrush visits lastest month: 36
- Host name: 217-160-0-30.elastic-ssl.ui-r.com
- IP address: 217.160.0.30
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "b.fab"
About us - bfab.bio
Our platform is built on anaerobic and aerobic microbial production hosts to provide flexibility in the process design and adaptation to specific product requirements. We apply laboratory automation, high-throughput …See details»
Team - bfab.bio
Armin Kubis, Head of Synthetic Biology Armin joined the b.fab team in April 2021 as Head of Synthetic Biology. He is in charge of the molecular biology and metabolic engineering at b.fab. Armin holds a B.Sc. in Biochemistry from the …See details»
b.fab - Crunchbase Company Profile & Funding
B.fab specializes in the conversion of CO2 and hydrogen from renewable energy into biotechnological value chains.See details»
b.fab GmbH | The Annual GPCA Forum
Nov 4, 2024 b.fab offers pathway design, strain engineering, process development and technology licenses to its customers from the chemical, cosmetic, feed and food industry. Category: Climate Action Country: Germany …See details»
b.fab 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for b.fab. Use the PitchBook Platform to explore the full profile.See details»
b.fab GmbH | F6S
B.fab is specialized in C1 Bioeconomy und uses CO2 as feedstock. In a first step, we efficiently convert CO2 into formate with an electrolyzer. In a second step, formate is used in a …See details»
b.fab GmbH - VentureRadar
Privately Held Develops a synthetic pathway in microbial hosts, utilizing formic acid as the sole carbon source for sustainable bio-production. "b.fab is specialized in the efficient conversion of …See details»
b.fab GmbH - StartGreen
Beschreibung Die b.fab ist spezialisiert auf die effiziente Verwertung von CO2 und Wasserstoff (H2) aus regenerativer Energie in biotechnologischen Wertschöpfungsketten. Formiat spielt …See details»
CCU Projects Database
Company Description b.fab is specialized in the efficient conversion of CO2 and hydrogen (H2) from renewable energy into biotechnological value chains. They use formate as their central …See details»
b.fab GmbH
• Flexible working and self-organization opportunity • Work and life in one of the most exciting cities in Germany (Cologne) Are you interested? Then please send your meaningful …See details»
b.fab (b.fab GmbH) - startbase.com
Sector: - Company Stage: Seed Stage Business Model: - Customer Focus: - Founding Year: 2021 Team Size: n/a Handelsregister: Found Headquarter: Köln, DE Official Website: bfab.bio On …See details»
b.fab - EU-Startups
B.fab is specialized in the efficient conversion of CO2 and hydrogen (H2) from renewable energy into biotechnological value chains. CO2 and water are abundantly available and therefore it is …See details»
b.fab GmbH: Drug pipelines, Patents, Clinical trials - Synapse
Private Company| 2018| Nordrhein-Westfalen, Germany | www.bfab.bio Private Company| 2018| Nordrhein-Westfalen, Germany | www.bfab.bio Last update 01 Jun 2023 Overview Pipeline …See details»
A novel means of converting CO2 into aquafeeds
Nov 1, 2024 A new, safer and faster way of converting CO2 into protein suitable for aquafeeds is being developed by b.fab, a German startup which aims to help establish a network of simple …See details»
Technology - bfab.bio
In our laboratories we apply: Pathway design and engineering Miniaturization and lab automation High-throughput experimentation Advanced bioprocess development Due to the utilization of …See details»
b.fab (b.fab GmbH) - Startbase
Sektor: - Unternehmensphase: Seed Stage Geschäftsmodell: - Zielgruppe: - Gründungsjahr: 2021 Größe des Teams: n/a Handelsregister: Existiert Hauptquartier: Köln, DE Official Website: …See details»
Welcome Investors - bfab.bio
Pitch Deck b.fab If you have any question or want to get in contact with us, then please feel free to send an email to [email protected]See details»
Phase I Study of the Anti-IL-33 Fab RO7303359 in Geographic …
3 days ago Interleukin (IL)-33 is a potent pro-inflammatory cytokine and a potential target in age-related macular degeneration (AMD) pathophysiology. This study evaluated RO7303359, an …See details»
b.fab receives funding from BMBF for CO2 utilization in biopolymers
B.fab GmbH received the official letter for project funding from BMBF (German Federal Ministry of Education and Research) at the end of February as part of the call CO2-WIN. The project …See details»
A novel means of converting CO2 into aquafeeds - bfab.bio
B.fab is featured in an article on The FishSite with their story how the company got to the aquaculture industry. A novel means of converting CO2 into aquafeedsSee details»